Aspen Aerogels (NYSE:ASPN) Shares Cross Above 50-Day Moving Average – Here’s Why

Aspen Aerogels, Inc. (NYSE:ASPN)’s stock price passed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $3.24 and traded as high as $3.60. Aspen Aerogels shares last traded at $3.5450, with a volume of 834,851 shares changing hands.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on ASPN shares. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Aspen Aerogels in a report on Monday, December 29th. Zacks Research raised shares of Aspen Aerogels from a “strong sell” rating to a “hold” rating in a research note on Thursday, January 15th. Barclays lowered their price objective on Aspen Aerogels from $6.00 to $4.00 and set an “underweight” rating on the stock in a research note on Friday, November 7th. Finally, Canaccord Genuity Group dropped their price target on shares of Aspen Aerogels from $10.00 to $5.00 and set a “buy” rating for the company in a research note on Friday, November 7th. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, two have given a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $12.67.

Aspen Aerogels Trading Down 0.7%

The company has a fifty day simple moving average of $3.24 and a two-hundred day simple moving average of $5.67. The company has a current ratio of 3.94, a quick ratio of 3.33 and a debt-to-equity ratio of 0.28. The company has a market cap of $292.99 million, a PE ratio of -0.95 and a beta of 2.94.

Aspen Aerogels (NYSE:ASPN) last announced its quarterly earnings data on Thursday, November 6th. The construction company reported ($0.06) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.05). Aspen Aerogels had a negative net margin of 86.52% and a negative return on equity of 0.20%. The firm had revenue of $73.02 million during the quarter, compared to analyst estimates of $73.42 million. During the same quarter in the previous year, the business posted ($0.17) earnings per share. Aspen Aerogels’s revenue for the quarter was down 37.8% compared to the same quarter last year. Aspen Aerogels has set its FY 2025 guidance at -4.150–4.050 EPS. Analysts anticipate that Aspen Aerogels, Inc. will post 0.17 EPS for the current year.

Insider Activity

In other news, CEO Donald R. Young sold 56,845 shares of the company’s stock in a transaction on Thursday, November 13th. The shares were sold at an average price of $3.23, for a total value of $183,609.35. Following the completion of the transaction, the chief executive officer owned 494,011 shares in the company, valued at approximately $1,595,655.53. This represents a 10.32% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 3.40% of the company’s stock.

Hedge Funds Weigh In On Aspen Aerogels

Several hedge funds have recently made changes to their positions in the company. Nisa Investment Advisors LLC lifted its holdings in shares of Aspen Aerogels by 1,094.8% in the 2nd quarter. Nisa Investment Advisors LLC now owns 4,791 shares of the construction company’s stock valued at $28,000 after purchasing an additional 4,390 shares during the last quarter. Balance Wealth LLC acquired a new position in Aspen Aerogels during the fourth quarter worth approximately $29,000. Jefferson Bridge Capital LLC purchased a new stake in Aspen Aerogels in the fourth quarter valued at approximately $32,000. SBI Securities Co. Ltd. boosted its holdings in shares of Aspen Aerogels by 67.3% in the second quarter. SBI Securities Co. Ltd. now owns 6,343 shares of the construction company’s stock valued at $38,000 after acquiring an additional 2,551 shares during the period. Finally, Tower Research Capital LLC TRC boosted its holdings in shares of Aspen Aerogels by 184.6% in the second quarter. Tower Research Capital LLC TRC now owns 7,235 shares of the construction company’s stock valued at $43,000 after acquiring an additional 4,693 shares during the period. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.